JAZZ Software Enables Better Multiple Sclerosis Lesion Detection in Record Time

Multiple sclerosis (MS) patients require annual MRI follow-ups to monitor disease progression, as detecting new lesions can trigger critical treatment adjustments. However, the radiological assessment of these scans is notoriously tedious and error-prone, given that patients can often present with dozens if not hundreds of lesions in the complex brain anatomy.

Across three independent, renowned medical centres (Stanford University, USA, University Hospital Zürich, Switzerland, and Hôpital Poincaré, Paris, France) the Jazz™ platform increased new MS lesion detection sensitivity by 260%, a vital clinical improvement given its therapeutic impact, while reducing reading time by 75% compared to standard radiological methods.